TissGeneSummary for AQP6 |
Gene summary |
Basic gene information | Gene symbol | AQP6 |
Gene name | aquaporin 6, kidney specific | |
Synonyms | AQP2L|KID | |
Cytomap | UCSC genome browser: 12q13 | |
Type of gene | protein-coding | |
RefGenes | NM_001652.3, NM_053286.1, | |
Description | AQP-6aquaporin 2-like, kidney specificaquaporin-6aquaporin-6, kidney specifichKIDkidney-specific aquaporin | |
Modification date | 20141207 | |
dbXrefs | MIM : 601383 | |
HGNC : HGNC | ||
Ensembl : ENSG00000086159 | ||
HPRD : 03226 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_AQP6 | |
BioGPS: 363 | ||
Pathway | NCI Pathway Interaction Database: AQP6 | |
KEGG: AQP6 | ||
REACTOME: AQP6 | ||
Pathway Commons: AQP6 | ||
Context | iHOP: AQP6 | |
ligand binding site mutation search in PubMed: AQP6 | ||
UCL Cancer Institute: AQP6 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Kidney | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | KIRC,KIRP,KICH | |
Reference showing the relevant tissue of AQP6 | ||
Description by TissGene annotations | Have significant anti-correlated miRNA |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for AQP6 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KIRP | -1.372226851 | 5.624754399 | -6.99698125 | 1.41E-18 | 7.02E-17 |
KICH | 2.362749149 | 6.915453149 | -4.552704 | 2.04E-05 | 6.08E-05 |
KIRC | -2.312235185 | 5.680288426 | -7.992523611 | 3.89E-45 | 2.36E-43 |
THCA | -1.574774309 | -2.906011597 | 1.331237288 | 2.65E-07 | 1.09E-06 |
Top |
TissGene-miRNA for AQP6 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
UCS | hsa-miR-421 | MIMAT0003339 | 0.0083 | -0.35 | 56 |
Top |
TissGeneMut for AQP6 |
TissGeneSNV for AQP6 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.G256E | SKCM | 2 |
p.A67T | UCEC | 2 |
p.R9C | COAD | 1 |
p.S77G | SARC | 1 |
p.S96C | HNSC | 1 |
p.F39L | HNSC | 1 |
p.S270F | SKCM | 1 |
p.G208A | LUSC | 1 |
p.A84V | SKCM | 1 |
p.R127* | SKCM | 1 |
p.G260E | SKCM | 1 |
p.S171F | HNSC | 1 |
p.A59V | STAD | 1 |
p.G110E | THCA | 1 |
p.S44L | HNSC | 1 |
p.G251S | BLCA | 1 |
p.G131E | SKCM | 1 |
p.G7E | SKCM | 1 |
p.F40L | LUAD | 1 |
p.F39L | COAD | 1 |
p.A116S | HNSC | 1 |
p.P83T | OV | 1 |
p.G114R | SKCM | 1 |
p.E269K | SKCM | 1 |
p.A81T | STAD | 1 |
p.A26V | LIHC | 1 |
p.F62L | BLCA | 1 |
p.A224T | STAD | 1 |
p.K75N | UCEC | 1 |
p.W217R | LUAD | 1 |
p.A88D | BLCA | 1 |
p.S171Y | READ | 1 |
p.V253I | STAD | 1 |
Top |
TissGeneCNV for AQP6 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for AQP6 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for AQP6 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for AQP6 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for AQP6 |
TissGeneDrug for AQP6 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for AQP6 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C3665333 | Keratitis-Ichthyosis-Deafness Syndrome | 2 | BeFree |
umls:C0027859 | Acoustic Neuroma | 1 | BeFree |
umls:C0028768 | Obsessive-Compulsive Disorder | 1 | BeFree |
umls:C0029421 | Osteochondritis Dissecans | 1 | BeFree |